期刊文献+

骨髓增生异常综合征患者染色体异常与细胞形态学的相关性分析 被引量:1

Correlation between Chromosomal Abnormality and Cell Morphology with Myelodysplastic Syndrome Patients
下载PDF
导出
摘要 目的总结分析骨髓增生异常综合征患者(MDS)细胞形态学异常与染色体异常的相关性。方法回顾性分析82例MDS患者完整的病例资料,探讨MDS细胞形态学异常与FISH检测染色体异常的相关性。结果 82例MDS患者中,染色体异常45例,+8为出现频率最高的染色体异常,其中单纯+8异常8例,-5和5q-各6例、20q-7例、-7和7q-各5例、复杂核型(>3种异常)6例、+8伴20q-1例,5q-伴20q-1例。核型异常组与核型正常组之间原始细胞比例、幼红细胞巨幼样变及核畸形、巨核细胞系发育异常(单圆核巨核细胞、多圆核巨核细胞、小巨核细胞)比例差异有统计学意义(P<0.05)。高危组与低危组间、低危组与中危组间核型异常比例差异有统计学意义(P<0.05)。结论 MDS患者的染色体异常与形态学改变可能相关。 Objective To investigate the correlation between morphological abnormalities and abnormal myelodysplastic syn-dromes(MDS)cloning.Methods 82 cases of MDS were collected with complete FISH and morphological abnormalities. The relationship between MDS cell morphology and chromosome abnormality was investigated.Results 45 cases of chromo-somal abnormalities were found,and +8 were the most frequent chromosomal abnormalities.8 cases were +8,-5 and 5q-were 6,20q-were 7,-7 and 7q-were 5,complex karyotypes(〉3 abnormalities)were 6.There were statistically significant differences in the proportion of primordial cells,megakaryocyte dysplasia,megakaryocyte abnormalities between karyotype abnormal group and karyotype normal group(P〈0.05).There were statistically significant differences in the proportion of abnormal karyotype among high risk group and low risk group,the low risk group and medium risk group(P〈0.05).Con-clusion The chromosomal abnormalities of MDS patients would be related to morphological changes.
出处 《现代检验医学杂志》 CAS 2017年第6期71-73,共3页 Journal of Modern Laboratory Medicine
关键词 骨髓增生异常综合征 发育异常 荧光原味杂交 myelodysplastic syndrome dysplasia fluorescence in situ hybridization
  • 相关文献

参考文献3

二级参考文献14

  • 1Garcia-Manero G.Prognosis of myelodysplastic syndromes[J].Hematdogy the American Society of Hematol Education Program,2010,2010(1):330-337.
  • 2Kawankar N,Vundinti BR.Cytogenetic abnormalities in myelodysplastic syndrome:an overview[J].Hematology,2011,16(3):131-138.
  • 3Sabattini E,Bacci F,Sagramoso C,et al.WHO classification of tumours of haematopoietic and lymphoid tissues in 2008:an overview[J].Pathologica,2010,102(3):83-87.
  • 4Shaffer LG,Tommerup N.ISCN 2005:An international system for human cytogenetic nomenclature[M].Switzerland:Karger basel publication,2005:55-83.
  • 5Romeo M,Chauffaille Mde L,Silva MR,et al.Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients[J].Leuk Res,2002,26(11):993-996.
  • 6Bernasconi P, Klersy C, Boni M, et al. World Health Organization classification in combination with cyto- genetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syn- dromes[J]. Br J Haematol, 2007,137 (3) : 193-205.
  • 7Vardiman JW, Thiele J, Arber DA, et al. The 2008 re- vision of the World Health Organization(WHO) clas- sification of myeloid neoplasms and acute leukemia.. rationale and important changes [J]. Blood, 2009,114 (5) ..937-951.
  • 8Valent P, Horny Hp, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes:consensus statements and report from a working conference [J]. Leuk Res, 2007,31 (6) : 727-736.
  • 9Sole F, Espinet B, Sanz GF, et al. Incidence character- ization and prognostic significance of chromosome ab- normalities in 640 patients with primary myelodys- plastic syndromes. Group cooperativo espanol de cito- genetica hematologica[J]. Br J Haematol, 2000, 108 (2) :346-356.
  • 10李磷,刘旭平,聂玲,于明华,张悦,秦铁军,肖志坚.原发性骨髓增生异常综合征染色体核型异常特征及其预后意义的研究[J].中华血液学杂志,2009,30(4):217-222. 被引量:25

共引文献33

同被引文献9

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部